Healthcare Triangle, Inc. Files Amended 10-K/A: Key Details and Shareholder Insights

Executive Summary

Healthcare Triangle, Inc. (“HTI”, Nasdaq: HCTI) has filed Amendment No. 1 to its Annual Report on Form 10-K for the fiscal year ended December 31, 2025. This amendment addresses a correction in the signature of the independent registered public accounting firm, SRCO Professional Corporation, on their audit report. The amendment restates the original audit report and includes updated certifications from management as required by the Sarbanes-Oxley Act.

Key Highlights

• Nature of Amendment: The amendment corrects a clerical error in the original audit report signature and does not update any financials or other disclosures except for the audit report and related certifications.
• Restated Audit Report: The audit reports for 2025 and 2024 indicate that the consolidated financial statements fairly present the company’s financial position, in all material respects, in accordance with US GAAP.
• Going Concern Warning: The auditors raised substantial doubt about HTI’s ability to continue as a going concern. The company has yet to achieve profitable operations, is experiencing negative cash flow from operating activities, and is dependent on additional equity or other financings to fund ongoing operations.
• Significant Net Losses: For the year ended December 31, 2025, HTI reported a comprehensive loss attributable to stockholders of (\$9.4 million) and a deemed dividend of (\$7.4 million). For 2024, the comprehensive loss was also significant.
• Stockholders’ Equity (Deficit): As of December 31, 2025, total stockholders’ equity was \$9.9 million, but in some periods within the filing, negative equity positions are reported (e.g., (\$5.1 million)), reflecting volatility and capital structure changes.
• Equity Issuance & Dilution: During 2025, the company issued a significant number of shares for services, acquisitions, cash, and conversions of debt to equity, including:
  • 14,000 shares issued for services
  • Conversion of 50 shares from debt to equity
  • Issuance of 23,135 shares for acquisitions
  • Issuance of preferred stock in connection with acquisition of customer contracts valued at \$7.4 million
  • Proceeds from equity issuance totaling \$17.0 million in 2025
• Non-Cash Expenses: Notable non-cash expenses include share-based compensation of \$451,000 in 2025.
• No Critical Audit Matters: The auditor did not identify any critical audit matters for 2025. For 2024, the critical audit matter related to the company’s ability to continue as a going concern.
• Corporate Structure & Business Focus:
  • HTI and its wholly owned subsidiaries serve the healthcare sector, focusing on pharmaceutical companies, healthcare providers, and payers/insurers.
  • HTI’s strategy is to modernize IT infrastructure, accelerate clinical trial processes, and deliver advanced healthcare solutions.
  • The company operates through three business segments: Software Services, Managed Services and Support, and Corporate & Others.
• Emerging Growth Company Status: HTI qualifies as an emerging growth company under the JOBS Act and has elected to use certain reduced disclosure requirements and implementation delays for new or revised accounting standards, which may impact transparency compared to larger reporting companies.

Shareholder-Impactful and Price-Sensitive Items

1. Going Concern Doubt: The auditor’s warning about HTI’s ability to continue as a going concern is highly material and may be price-sensitive. This signals financial instability and potential risk of insolvency if additional capital is not raised.
2. Ongoing Losses and Dilution: HTI continues to operate at a significant net loss and has heavily diluted shareholders by issuing large amounts of new shares for services, acquisitions, and conversions. This level of dilution and continuing losses can negatively affect share value, especially for existing investors.
3. Massive Capital Raises and Conversions: The company raised over \$17 million through equity during 2025 and issued preferred stock valued at \$7.4 million for acquisitions. While this provides needed liquidity, it also increases dilution risk.
4. Restatement of Audit Report: This amendment was triggered by a clerical error in the auditor’s signature, not by any changes in financial performance. While not a direct financial restatement, repeated amendments or errors can erode investor confidence in management’s controls and reporting accuracy.

Other Items of Note

• The company’s financial statements do not include any adjustments for the outcome of the going concern uncertainty.
• HTI continues to invest in technology and acquisitions, as seen in the material non-cash transactions and equity-based acquisitions.
• The company’s status as a smaller reporting company and emerging growth company means it provides fewer disclosures than larger peers and delays adoption of some new accounting rules.

Conclusion

Investors should exercise caution: HTI’s amendment to its 10-K does not change its financial results, but the company’s ongoing need for capital, substantial losses, and the auditor’s going concern warning are serious red flags. The ongoing issuance of shares and preferred stock for acquisitions and services further dilutes current shareholders and may continue to pressure the share price. The company’s ability to secure future financing and achieve profitability will be critical to its survival and future share performance.

This news is material and price-sensitive, as it highlights both operational risks and ongoing financial concerns that could impact share value.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors should conduct their own due diligence and consult with professional advisors before making investment decisions related to Healthcare Triangle, Inc. or any other security.

View Healthcare Triangle, Inc. Historical chart here